Cargando…

Health promotion intervention among women with recent gestational diabetes mellitus: penetration, participation, and baseline findings from the Face-it randomized controlled trial

INTRODUCTION: Face-it is a randomized controlled trial for women with recent gestational diabetes mellitus (GDM) and their families designed to evaluate the effect of a health promotion intervention on type 2 diabetes mellitus (T2DM) risk and quality of life. This study examined (1) the penetration...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensen, Nanna Husted, Kragelund Nielsen, Karoline, Dahl-Petersen, Inger Katrine, Kampmann, Ulla, Damm, Peter, Ovesen, Per, Mathiesen, Elisabeth Reinhardt, Vinter, Christina Anne, Davidsen, Emma, Thøgersen, Maja, Timm, Anne, Andersen, Lise Lotte Torvin, Knorr, Sine, Jensen, Dorte Møller, Maindal, Helle Terkildsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551966/
https://www.ncbi.nlm.nih.gov/pubmed/37793679
http://dx.doi.org/10.1136/bmjdrc-2023-003529
_version_ 1785115878420905984
author Jensen, Nanna Husted
Kragelund Nielsen, Karoline
Dahl-Petersen, Inger Katrine
Kampmann, Ulla
Damm, Peter
Ovesen, Per
Mathiesen, Elisabeth Reinhardt
Vinter, Christina Anne
Davidsen, Emma
Thøgersen, Maja
Timm, Anne
Andersen, Lise Lotte Torvin
Knorr, Sine
Jensen, Dorte Møller
Maindal, Helle Terkildsen
author_facet Jensen, Nanna Husted
Kragelund Nielsen, Karoline
Dahl-Petersen, Inger Katrine
Kampmann, Ulla
Damm, Peter
Ovesen, Per
Mathiesen, Elisabeth Reinhardt
Vinter, Christina Anne
Davidsen, Emma
Thøgersen, Maja
Timm, Anne
Andersen, Lise Lotte Torvin
Knorr, Sine
Jensen, Dorte Møller
Maindal, Helle Terkildsen
author_sort Jensen, Nanna Husted
collection PubMed
description INTRODUCTION: Face-it is a randomized controlled trial for women with recent gestational diabetes mellitus (GDM) and their families designed to evaluate the effect of a health promotion intervention on type 2 diabetes mellitus (T2DM) risk and quality of life. This study examined (1) the penetration and participation rates for the Face-it trial, (2) the characteristics of the participating women and the potential differences in characteristics according to partner participation status, and (3) representativity of the women at baseline. RESEARCH DESIGN AND METHODS: We identified women with GDM during pregnancy and invited them and their partners to a baseline examination 10–14 weeks after delivery. Representativity was assessed by comparing the baseline participants with non-participating women, the general population of women with GDM delivering in Denmark, and populations from other intervention trials. RESULTS: The penetration rate was 38.0% (867/2279) and the participation rate was 32.9% (285/867). The 285 women who attended baseline had a mean age of 32.7 (±4.8) years and body mass index (BMI) of 28.1 (±5.4) kg/m(2), and 69.8% had a partner who participated. The women participating with a partner were more often primiparous, born in Denmark (82.8% vs 68.2%), were younger, and more often had a BMI ≤24.9 kg/m(2) (35.7% vs 21.2%) compared with women without a partner. Compared with the general population of women with GDM in Denmark, these women broadly had similar degree of heterogeneity, but had higher rates of primiparity and singleton deliveries, and lower rates of preterm delivery and prepregnancy obesity. CONCLUSIONS: The penetration and participation rates were acceptable. We found a high rate of partner participation. Overall, women participating with a partner were comparable with those participating without a partner. Participating women were broadly similar to the general national GDM population, however with prepregnancy obesity, multiparity, preterm delivery, and multiple pregnancy being less represented. TRIAL REGISTRATION NUMBER: NCT03997773.
format Online
Article
Text
id pubmed-10551966
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-105519662023-10-06 Health promotion intervention among women with recent gestational diabetes mellitus: penetration, participation, and baseline findings from the Face-it randomized controlled trial Jensen, Nanna Husted Kragelund Nielsen, Karoline Dahl-Petersen, Inger Katrine Kampmann, Ulla Damm, Peter Ovesen, Per Mathiesen, Elisabeth Reinhardt Vinter, Christina Anne Davidsen, Emma Thøgersen, Maja Timm, Anne Andersen, Lise Lotte Torvin Knorr, Sine Jensen, Dorte Møller Maindal, Helle Terkildsen BMJ Open Diabetes Res Care Epidemiology/Health services research INTRODUCTION: Face-it is a randomized controlled trial for women with recent gestational diabetes mellitus (GDM) and their families designed to evaluate the effect of a health promotion intervention on type 2 diabetes mellitus (T2DM) risk and quality of life. This study examined (1) the penetration and participation rates for the Face-it trial, (2) the characteristics of the participating women and the potential differences in characteristics according to partner participation status, and (3) representativity of the women at baseline. RESEARCH DESIGN AND METHODS: We identified women with GDM during pregnancy and invited them and their partners to a baseline examination 10–14 weeks after delivery. Representativity was assessed by comparing the baseline participants with non-participating women, the general population of women with GDM delivering in Denmark, and populations from other intervention trials. RESULTS: The penetration rate was 38.0% (867/2279) and the participation rate was 32.9% (285/867). The 285 women who attended baseline had a mean age of 32.7 (±4.8) years and body mass index (BMI) of 28.1 (±5.4) kg/m(2), and 69.8% had a partner who participated. The women participating with a partner were more often primiparous, born in Denmark (82.8% vs 68.2%), were younger, and more often had a BMI ≤24.9 kg/m(2) (35.7% vs 21.2%) compared with women without a partner. Compared with the general population of women with GDM in Denmark, these women broadly had similar degree of heterogeneity, but had higher rates of primiparity and singleton deliveries, and lower rates of preterm delivery and prepregnancy obesity. CONCLUSIONS: The penetration and participation rates were acceptable. We found a high rate of partner participation. Overall, women participating with a partner were comparable with those participating without a partner. Participating women were broadly similar to the general national GDM population, however with prepregnancy obesity, multiparity, preterm delivery, and multiple pregnancy being less represented. TRIAL REGISTRATION NUMBER: NCT03997773. BMJ Publishing Group 2023-10-03 /pmc/articles/PMC10551966/ /pubmed/37793679 http://dx.doi.org/10.1136/bmjdrc-2023-003529 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Epidemiology/Health services research
Jensen, Nanna Husted
Kragelund Nielsen, Karoline
Dahl-Petersen, Inger Katrine
Kampmann, Ulla
Damm, Peter
Ovesen, Per
Mathiesen, Elisabeth Reinhardt
Vinter, Christina Anne
Davidsen, Emma
Thøgersen, Maja
Timm, Anne
Andersen, Lise Lotte Torvin
Knorr, Sine
Jensen, Dorte Møller
Maindal, Helle Terkildsen
Health promotion intervention among women with recent gestational diabetes mellitus: penetration, participation, and baseline findings from the Face-it randomized controlled trial
title Health promotion intervention among women with recent gestational diabetes mellitus: penetration, participation, and baseline findings from the Face-it randomized controlled trial
title_full Health promotion intervention among women with recent gestational diabetes mellitus: penetration, participation, and baseline findings from the Face-it randomized controlled trial
title_fullStr Health promotion intervention among women with recent gestational diabetes mellitus: penetration, participation, and baseline findings from the Face-it randomized controlled trial
title_full_unstemmed Health promotion intervention among women with recent gestational diabetes mellitus: penetration, participation, and baseline findings from the Face-it randomized controlled trial
title_short Health promotion intervention among women with recent gestational diabetes mellitus: penetration, participation, and baseline findings from the Face-it randomized controlled trial
title_sort health promotion intervention among women with recent gestational diabetes mellitus: penetration, participation, and baseline findings from the face-it randomized controlled trial
topic Epidemiology/Health services research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551966/
https://www.ncbi.nlm.nih.gov/pubmed/37793679
http://dx.doi.org/10.1136/bmjdrc-2023-003529
work_keys_str_mv AT jensennannahusted healthpromotioninterventionamongwomenwithrecentgestationaldiabetesmellituspenetrationparticipationandbaselinefindingsfromthefaceitrandomizedcontrolledtrial
AT kragelundnielsenkaroline healthpromotioninterventionamongwomenwithrecentgestationaldiabetesmellituspenetrationparticipationandbaselinefindingsfromthefaceitrandomizedcontrolledtrial
AT dahlpeterseningerkatrine healthpromotioninterventionamongwomenwithrecentgestationaldiabetesmellituspenetrationparticipationandbaselinefindingsfromthefaceitrandomizedcontrolledtrial
AT kampmannulla healthpromotioninterventionamongwomenwithrecentgestationaldiabetesmellituspenetrationparticipationandbaselinefindingsfromthefaceitrandomizedcontrolledtrial
AT dammpeter healthpromotioninterventionamongwomenwithrecentgestationaldiabetesmellituspenetrationparticipationandbaselinefindingsfromthefaceitrandomizedcontrolledtrial
AT ovesenper healthpromotioninterventionamongwomenwithrecentgestationaldiabetesmellituspenetrationparticipationandbaselinefindingsfromthefaceitrandomizedcontrolledtrial
AT mathiesenelisabethreinhardt healthpromotioninterventionamongwomenwithrecentgestationaldiabetesmellituspenetrationparticipationandbaselinefindingsfromthefaceitrandomizedcontrolledtrial
AT vinterchristinaanne healthpromotioninterventionamongwomenwithrecentgestationaldiabetesmellituspenetrationparticipationandbaselinefindingsfromthefaceitrandomizedcontrolledtrial
AT davidsenemma healthpromotioninterventionamongwomenwithrecentgestationaldiabetesmellituspenetrationparticipationandbaselinefindingsfromthefaceitrandomizedcontrolledtrial
AT thøgersenmaja healthpromotioninterventionamongwomenwithrecentgestationaldiabetesmellituspenetrationparticipationandbaselinefindingsfromthefaceitrandomizedcontrolledtrial
AT timmanne healthpromotioninterventionamongwomenwithrecentgestationaldiabetesmellituspenetrationparticipationandbaselinefindingsfromthefaceitrandomizedcontrolledtrial
AT andersenliselottetorvin healthpromotioninterventionamongwomenwithrecentgestationaldiabetesmellituspenetrationparticipationandbaselinefindingsfromthefaceitrandomizedcontrolledtrial
AT knorrsine healthpromotioninterventionamongwomenwithrecentgestationaldiabetesmellituspenetrationparticipationandbaselinefindingsfromthefaceitrandomizedcontrolledtrial
AT jensendortemøller healthpromotioninterventionamongwomenwithrecentgestationaldiabetesmellituspenetrationparticipationandbaselinefindingsfromthefaceitrandomizedcontrolledtrial
AT maindalhelleterkildsen healthpromotioninterventionamongwomenwithrecentgestationaldiabetesmellituspenetrationparticipationandbaselinefindingsfromthefaceitrandomizedcontrolledtrial